Premca Extra Income Fund LP v. Angle

Court of Appeals for the First Circuit·Decided June 5, 2026·No. 25-1192·Published

Opinion

United States Court of Appeals For the First Circuit

No. 25-1192

PREMCA EXTRA INCOME FUND LP, individually and on behalf of all others similarly situated,

Plaintiff, Appellant,

DYLAN DAS,

Plaintiff,

v.

COLIN M. ANGLE; JULIE ZEILER,

Defendants, Appellees,

IROBOT CORPORATION,

Defendant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. William G. Young, U.S. District Judge]

Before

Rikelman, Lynch, and Aframe, Circuit Judges.

Christopher P. T. Tourek, with whom Joshua B. Silverman, Genc Arifi, and Pomerantz LLP were on brief, for appellant. Alisha Q. Nanda, with whom James R. Carroll, Rene H. DuBois, and Skadden, Arps, Slate, Meagher & Flom LLP were on brief, for appellees. June 5, 2026 AFRAME, Circuit Judge. In August 2022, Amazon, Inc.,

the online retailer, and iRobot, Inc., a robotics company best

known for inventing a popular robot vacuum cleaner called the

Roomba, announced their intention to merge. Over the next

approximately eighteen months, Amazon and iRobot sought clearance

for the merger from domestic and international antitrust

regulators. In January 2024, when approval from United States

and European Union authorities seemed doubtful, Amazon and iRobot

terminated their merger attempt.

Following the abandoned merger, iRobot shareholders,

led by Premca Extra Income Fund, LP ("Premca"), brought a

securities fraud class action against iRobot, Colin Angle,

iRobot's chief executive officer, and Julie Zeiler, iRobot's chief

financial officer. After Premca filed an amended complaint, the

defendants moved to dismiss it for failing to state a claim,

arguing that it neither identified a statement that contained an

actionable material misrepresentation or omission nor adequately

alleged scienter. The district court agreed on both fronts and

dismissed the complaint with prejudice. Premca appealed. After

oral argument, iRobot entered Chapter 11 bankruptcy, which

resulted in a temporary stay of the appeal. During the stay, the

parties jointly requested to dismiss iRobot from the appeal but

to have the appeal proceed with respect to Angle and Zeiler (the

"individual defendants"). We granted that request. - 3 - We now conclude that the district court correctly

dismissed the amended complaint for all statements identified by

Premca except for the August 24, 2023, modified proxy statement.

As we explain, the amended complaint plausibly alleges that an

opinion expressed in iRobot's modified proxy statement -- namely,

that the company expected regulatory approval for the merger -- is

actionable because it omitted important contrary information about

European approval in circumstances that adequately suggest

scienter.

I.

Because we are evaluating the grant of a motion to

dismiss under Federal Rule of Civil Procedure 12(b)(6), we

describe the well-pleaded allegations from the amended complaint,

supplemented by "'documents the authenticity of which are not

disputed by the parties,' 'official public records,' and

'documents sufficiently referred to in the complaint.'" Constr.

Indus. & Laborers Joint Pension Tr. v. Carbonite, Inc., 22 F.4th

1, 4 (1st Cir. 2021) (quoting Mehta v. Ocular Therapeutix, Inc.,

955 F.3d 194, 198 (1st Cir. 2020)).

We start with some background on the primary antitrust

authorities involved, namely, the European Commission ("EC") in

the European Union and the Federal Trade Commission ("FTC") in

the United States. We then turn to the details of the merger and

the travel of the case. - 4 - A. Regulatory Background

In the European Union, the EC reviews mergers that

exceed certain revenue thresholds, including the merger at issue

here. Parties proposing a covered merger must formally notify

the EC of the transaction, and often, there are pre-notification

communications between the EC and the merging parties. After

formal notification, the EC has twenty-five working days to

conduct a Phase I review. During that review, the EC will obtain

information from the merging companies, communicate with them,

and hold a "state-of-play meeting" to disclose the investigation

results. Following Phase I, the EC will either (1) "clear[]" the

merger -- unconditionally or subject to accepted remedies -- or

(2) open a Phase II investigation.

The EC will launch a Phase II investigation if it has

concerns about the merger's anticompetitive effect on the European

market. A Phase II investigation lasts ninety working days, but

the EC may extend it. If, following Phase II, the EC concludes

that the proposed merger will impede competition, it will send

the parties a statement of objections. The parties may then

respond to the objections, review the EC's file, and request an

oral hearing before an independent hearing officer. In 2022, 2.1%

of mergers proposed to the EC entered Phase II.

In the United States, merging companies involved in

transactions of a certain size must file a pre-merger - 5 - notification, which either the FTC or the Department of Justice's

Antitrust Division reviews. See 15 U.S.C. § 18a(a), (b)(1)(A).

The FTC reviewed the merger at issue here, and thus we focus on

the statutory requirements as applicable to that agency. The

pre-merger notification triggers a thirty-day waiting period while

the FTC conducts its review. See id. § 18a(b)(1)(B). If, during

the waiting period, the FTC decides that it needs more

information, it may make a so-called second request for

information. See id. § 18a(e). The FTC may approve the merger

or sue to block it because of its anticompetitive effects. See

id. § 18a(f). Throughout the process, the FTC will continue to

engage with the merging parties. In 2022, the FTC issued a second

request for information in less than one percent of the mergers

it reviewed.

Finally, we note that the United Kingdom's Competition

and Markets Authority ("CMA") also reviewed this merger. Its

review, however, is only tangential to this case and so we do not

provide further details on its regulatory processes.

B. iRobot and Amazon's Merger Attempt

iRobot was founded in 1990 by Angle and two colleagues.

Initially, iRobot built robots mostly for the military, but by

the early 2000s, the company shifted its focus to consumer

products. Its primary product is the Roomba, the well-known robot

home vacuum that can sense dirt on its own. Despite initial - 6 - success, iRobot's market share began to decrease in 2014 as new

competitors entered the market. After a brief bump in sales

during the COVID-19 pandemic, iRobot's earnings continued to

decline.

In May 2022, Amazon contacted iRobot about a potential

acquisition. A couple months later, Amazon and iRobot agreed that

Amazon would pay sixty-one dollars per share to acquire iRobot.

The parties also agreed that Angle would continue as iRobot's CEO

after the merger.

Free access — add to your briefcase to read the full text and ask questions with AI

Premca Extra Income Fund LP v. Angle, (1st Cir. 2026).

Premca Extra Income Fund LP v. Angle (Premca Extra Income Fund LP v. Angle) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Ernst & Ernst v. Hochfelder
425 U.S. 185 (Supreme Court, 1976)
Basic Inc. v. Levinson
485 U.S. 224 (Supreme Court, 1988)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
United States v. Khounsavanh
113 F.3d 279 (First Circuit, 1997)
Aldridge v. A.T. Cross Corp.
284 F.3d 72 (First Circuit, 2002)
Mesko v. Cabletron System, Inc.
311 F.3d 11 (First Circuit, 2002)
Matrixx Initiatives, Inc. v. Siracusano
131 S. Ct. 1309 (Supreme Court, 2011)
Fire and Police Pension Assoc v. Abiomed, Inc.
778 F.3d 228 (First Circuit, 2015)
In Re: Biogen Inc. Sec. Litig. v.
857 F.3d 34 (First Circuit, 2017)
Puerto Rico Tele. Co., Inc. v. San Juan Cable LLC
874 F.3d 767 (First Circuit, 2017)
In Re: Ocular Therapeutix Inc v.
955 F.3d 194 (First Circuit, 2020)
Arbitrage Event-Driven Fund v. Tribune Media Company
39 F.4th 402 (Seventh Circuit, 2022)
Shash v. Biogen Inc.
84 F.4th 1 (First Circuit, 2023)